Maravai Lifesciences Holdings (MRVI) Goodwill & Intangibles (2020 - 2026)

Maravai Lifesciences Holdings' (MRVI) quarterly Goodwill & Intangibles came in at $274.3 million in Q1 2026, up 35.14% year-on-year from $203.0 million in Q1 2025, and down 2.37% quarter-over-quarter from $281.0 million in Q4 2025.

Maravai Lifesciences Holdings (MRVI) Goodwill & Intangibles (2020 - 2026) Analysis & Trends

Maravai Lifesciences Holdings' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $274.3 million for Q1 2026.

  • On a quarterly basis, Goodwill & Intangibles rose 35.14% year-over-year to $274.3 million in Q1 2026; TTM through Mar 2026 was $274.3 million, a 35.14% increase from a year earlier, with the FY2025 full-year figure at $281.0 million, down 20.82% from the prior year.
  • Goodwill & Intangibles fell to $274.3 million in Q1 2026 per MRVI's latest filing, from $281.0 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $561.2 million in Q2 2023 and bottomed at $203.0 million in Q1 2025.
  • The 5-year median for Goodwill & Intangibles is $373.6 million (2024), against an average of $411.3 million.
  • Across the five-year window, Goodwill & Intangibles surged 85.09% in 2022 and sank 62.42% in 2025, its largest moves.
  • Year by year, Goodwill & Intangibles stood at $500.4 million in 2022, then climbed by 9.32% to $547.0 million in 2023, then plunged by 35.13% to $354.8 million in 2024, then retreated by 20.82% to $281.0 million in 2025, then declined by 2.37% to $274.3 million in 2026.
  • Per Business Quant, the three latest MRVI Goodwill & Intangibles figures stand at $274.3 million (Q1 2026), $281.0 million (Q4 2025), and $315.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn -
4 BeOne Medicines 472.04 Bn 467.25 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.28 Bn 115.03 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.07 Bn 61.31 Bn 3.31 Bn
7 Belite Bio 62.66 Bn 62.66 Bn -
8 Argenx Se 56.16 Bn 50.98 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.56 Bn 34.55 Bn 959.66 Mn
10 Maravai Lifesciences Holdings 992.04 Mn 826.11 Mn 33.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 274.32 Mn
Dec 31, 2025 280.97 Mn
Sep 30, 2025 315.31 Mn
Jun 30, 2025 322.50 Mn
Mar 31, 2025 202.98 Mn
Dec 31, 2024 354.84 Mn
Sep 30, 2024 373.65 Mn
Jun 30, 2024 533.28 Mn
Mar 31, 2024 540.15 Mn
Dec 31, 2023 547.02 Mn
Sep 30, 2023 553.89 Mn
Jun 30, 2023 561.23 Mn
Mar 31, 2023 358.27 Mn
Dec 31, 2022 500.36 Mn
Sep 30, 2022 506.43 Mn
Jun 30, 2022 512.65 Mn
Mar 31, 2022 254.20 Mn
Dec 31, 2021 270.34 Mn
Sep 30, 2021 274.03 Mn
Jun 30, 2021 277.88 Mn